Hospital Volumes: An International Perspective on Germany - Presentation by Mark Pearson, April 2013

Hospital Volumes: An International Perspective on Germany. Presentation by Mark Pearson during the BMG-OECD Conference on Managing Hospital Volumes, Berlin, April 2013.

Briefing note for OECD Health Data 2012 - OECD-Gesundheitsdaten 2012: Deutschland im Vergleich

In Deutschland beliefen sich die Gesamtausgaben für Gesundheit im Jahr 2010 auf 11,6% des BIP und lagen damit um 2,1 Prozentpunkte über dem Durchschnitt der OECD-Länder von 9,5%.

Related Documents

• OECD Health Data 2012

Briefing note for OECD Health Data 2012: How Does Germany Compare

Health spending accounted for 11.6% of GDP in Germany in 2010, more than two percentage points higher than the OECD average of 9.5%.

Related Documents

• OECD Health Data 2012

Health: the high cost of diabetes

Across OECD countries some 83 million people suffer from diabetes. On current trends, that will rise to almost 100 million by 2030.

OECD Health Working Paper No. 56. Description of Alternative Approaches to Measure and Place a Value on Hospital Products in Seven OECD Countries

To assess the feasibility of using secondary data sets information to feed an output-based PPP approach for hospital services, we reviewed the main characteristics of diagnoses and procedures coding standards, DRG classification systems, and cost-finding methods used in selected OECD countries.

Related Documents

• No. 53 - Comparing Price Levels of Hospital Services Across Countries: Results of Pilot Study

OECD Health Working Paper No. 55: Mortality Amenable to Health Care in 31 OECD Countries: Estimates and Methodological Issues

The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.

Workshop on Better Health through Bio-medicine: Innovative Governance

For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.

Related Documents

• Task Force on Biomedicine and Health Innovation

OECD Health at a Glance 2009: Key findings for Germany

Germany spent 10.4% of GDP on health in 2007, more than the OECD average of 8.9%. Spending per person is also 20% higher than the OECD average.

Related Documents

• Health at a Glance 2009

A System of Health Accounts: Implementation in OECD countries

Information regarding the status of implementation of the System of Health Accounts in OECD countries, including SHA tables, working papers and reports on implementation.

A System of Health Accounts: Implementation - Germany

Information on the status of implementation of OECD's A System of Health Accounts in Germany.